Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jorge Mario Sánchez-Hoyos has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Medicinal plants in the treatment of skin diseases: an ethnobotanical study in various populations of the Bolívar department, Colombia

    by Sandra Milena Coronado Rios, Jorge Mario Sánchez-Hoyos, María Isabel Quintana-Torres, Harold Gómez-Estrada

    Background and Aims: Dermatological conditions are a significant source of global morbidity, as reported by the Global Burden of Disease study. In low- and middle-income countries with predominantly rural populations and limited healthcare access, traditional medicine is often the first line of treatment. In Colombia, despite the widespread use of medicinal plants to treat skin disorders, scientific documentation remains limited. This study aimed to record the plant species used by rural and semi-rural communities in the department of Bolívar for dermatological treatments.Methods: An ethnobotanical survey was conducted in eight localities in central and northern Bolívar, Colombia. A semi-structured questionnaire, based on TRAMIL guidelines, was used to collect data on four categories of dermatological conditions. The Informant Consensus Factor (ICF) and Fidelity index (FI) were calculated to assess the consistency and specificity of plant use.Key results: A total of 156 participants (109 women, 47 men) provided 385 use reports. The most frequently cited conditions included infections (165 reports), trauma-related injuries (136), insect bites (48), and inflammatory skin diseases (36), all associated with high ICF values. The species with the highest FI were Gliricidia sepium (21.01%) and Persea americana (20.29%) for infections, Aristolochia anguicida (50%) for insect bites, Heliotropium indicum (38.82%) and Bixa orellana (31.76%) for injuries, and Malachra alceifolia (44.44%) for inflammatory disorders. Leaves were the most frequently used plant part (72.73%), and poultices were the most common preparation method (39.74%). The data suggest a high degree of shared ethnobotanical knowledge, although a decline in intergenerational transmission was observed.Conclusions: Traditional medicine plays a crucial role in the management of dermatological conditions in the Colombian Caribbean region, highlighting the need for phytochemical and pharmacological studies to validate the efficacy and safety of medicinal plant species.


  • Open Access

    An Overview of Genus Malachra L.—Ethnobotany, Phytochemistry, and Pharmacological Activity

    by Leonor Cervantes-Ceballos, Jorge Sánchez-Hoyos, Fredys Sanchez-Hoyos, Erick Torres-Niño, Jairo Mercado-Camargo, Amparo Echeverry-Gómez, Karick Jotty Arroyo, Esther del Olmo-Fernández, Harold Gómez-Estrada

    The genus Malachra L. belongs to the family Malvaceae. It includes herbs or subshrubs of nine accepted species with approximately thirty synonyms, and it has been widely used in community folk medicine to treat health problems including inflammation, nasal obstruction, leishmaniasis, malaria, childbirth, kidney disorders, fever, respiratory tract diseases, among others. From the genus Malachra L., flavonoids, steroids, triterpenes, anthocyanins, leucoanthocyanins, saponins, carbohydrates, phenols, glycosides, and alkaloids have been isolated and identified. Some pharmacological reports have indicated that the genus has antidiarrheal, antiepileptic, antiulcerogenic, antioxidant, anticonvulsant, antiviral, anticancer, antibacterial, anthelmintic, and hepatoprotective properties. However, there have been limited studies of bioactive molecules with pharmacological and biological activities associated with Malachra alceifolia Jacq., Malachra capitata (L.) L., Malachra fasciata Jacq., Malachra radiata (L.) L., Malachra ruderalis Gürke., Malachra rudis Benth., Malachra helodes Mart., Malachra urens Poit. ex Ledeb. & Alderstam., and Malachra officinalis Klotzsch. In this review, we consider the conservation of these species to save the ancestral knowledge of their traditional use in populations, and their pharmacological potential for future studies in search of alternatives for solutions to diseases in humans and animals and tools for the design and search of potential bioactive compounds against infectious and non-infectious agents.